PIC
OLMA icon

Portland Investment Counsel’s Olema Pharmaceuticals OLMA Stock Holding History

Portland Investment Counsel’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$746K Hold
50,000
– – 0.24% 39
2025
Q4 		$1.25M Hold
50,000
– – 0.38% 28
2025
Q3 		$490K Hold
50,000
– – 0.13% 44
2025
Q2 		$231K Hold
50,000
– – 0.07% 42
2025
Q1 		$188K Buy
50,000
+25,000
+100% +$126K 0.06% 45
2024
Q4 		$146K Buy
25,000
+13,000
+108% +$130K 0.04% 50
2024
Q3 		$143K Buy
+12,000
New +$153K 0.05% 49

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Portland Investment Counsel's OLMA Position: Q1 2026 in Review

Portland Investment Counsel held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 50,000 shares worth $746K. The position accounts for 0.24% of the portfolio, ranked #39.

Portland Investment Counsel first reported a position in OLMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.25M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Portland Investment Counsel held 50,000 shares of Olema Pharmaceuticals worth $746K as of Q1 2026.
  • Portland Investment Counsel left its Olema Pharmaceuticals share count unchanged in Q1 2026.
  • Olema Pharmaceuticals made up 0.24% of Portland Investment Counsel's portfolio in Q1 2026, its #39 holding.
  • Portland Investment Counsel first reported a position in Olema Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Portland Investment Counsel's Olema Pharmaceuticals position peaked at $1.25M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Portland Investment Counsel's 13F filing for Q1 2026, filed 14 May 2026.